Co-Authors
This is a "connection" page, showing publications co-authored by Xavier Duval and François-Xavier Lescure.
Connection Strength
0.622
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.218
-
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review. Clin Microbiol Infect. 2018 Feb; 24(2):125-132.
Score: 0.181
-
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
Score: 0.058
-
Correction: Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department. PLoS One. 2021; 16(1):e0246458.
Score: 0.058
-
Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department. PLoS One. 2020; 15(12):e0243261.
Score: 0.057
-
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial. BMJ Open. 2018 09 01; 8(8):e023151.
Score: 0.049